东诚药业：公司不存在应披露而未披露事项

Core Viewpoint - Dongcheng Pharmaceutical (002675) emphasizes its commitment to comply with legal disclosure obligations and asserts that there are no undisclosed matters [1] Group 1 - The company responds to investor inquiries on November 26, indicating adherence to relevant laws and regulations regarding information disclosure [1] - Dongcheng Pharmaceutical will strictly follow the "Guidance No. 10 on Market Value Management for Listed Companies" to protect shareholder interests [1]